Stocks to Watch : Facebook Inc (NASDAQ:FB), International Business Machines (NYSE:IBM), Yelp Inc (NYSE:YELP), Gilead Sciences (NASDAQ:GILD)

Argus downgraded its rating on Facebook Inc (NASDAQ:FB) to Hold from Buy citing the rally in shares over the past year. The firm sees risks to Facebook’s acquisition of WhatsApp, adding the social media giant could see a “substantial” write-down should the texting platform not reach a billion users as planned. Facebook Inc (NASDAQ:FB) hares after opening at $68.18 on current trade day and currently trading at $67.84. Company price to sales ratio in past twelve months was calculated as 21.15 and price to cash ratio as 14.54. Facebook Inc (NASDAQ:FB) showed a negative weekly performance of -2.98%.

According to a new International Business Machines Corp. (NYSE:IBM) study, high-performing CMOs are integrating internal and external data to garner deep insights that, in turn, provide them with a much deeper understanding of their customers. International Business Machines Corp. (NYSE:IBM) shares rose 1.76% in current trading session and now at $185.39. IBM return on equity ratio is recorded as 98.20% and its return on assets is 16.40%. International Business Machines Corp. (NYSE:IBM) yearly performance is -13.82%.

Yelp Inc (NYSE:YELP) has changed the way many consumers search for restaurants, spurring Parker Swift to seek that goal for the automotive aftermarket with MechanicAdvisor.com, the site he founded it in 2006. Yelp Inc (NYSE:YELP) shares moved up 0.27% in current trading session and now at $87.23, while trading in range of $86.78 – $88.34. Yelp Inc (NYSE:YELP) year to date (YTD) performance is 25.87%.

Gilead Sciences (NASDAQ:GILD) EVP Paul Rutherford Carter sold 16,728 shares of the stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $79.32, for a total value of $1,326,864.96. Following the completion of the transaction, the executive vice president now directly owns 28,562 shares in the company, valued at approximately $2,265,538. Gilead Sciences, Inc. (NASDAQ:GILD) weekly performance is -5.69%. Shares of the company currently at $75.89. Gilead Sciences, Inc. (NASDAQ:GILD) distance from 50-day simple moving average (SMA50) is -4.29%. Analysts mean target price for the company is $100.17.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *